Aptar and Australian Research Council launch dry powder biologic research
What happened
Aptar Pharma announced a three-year research collaboration with Macquarie University, supported by the Australian Research Council. The project aims to investigate formulation approaches for the pulmonary delivery of biologic medicines. Researchers will evaluate how formulation variables influence aerosol performance when using Aptar's Orbital dry powder inhaler platform.
From finanznachrichten.de
Why it matters
The initiative addresses challenges faced by developers in delivering large doses of complex biologic molecules while maintaining formulation integrity. As interest in inhaled biologic therapies grows, this research aims to generate new insights into the interplay between formulation design and device performance.
From finanznachrichten.de
Who's involved
- AptarGlobal drug delivery company collaborating on a three-year research initiative.
- Australian Research CouncilAustralian government funding body supporting the research project.
Keep exploring
The entities involved
-
Aptar
company in Crystal Lake, United States
-
Australian Research Council
the Australian Government's main research funding body for tertiary institutions
Nothing else this week.